Leif Niclas Fredrik Löwgren
Director/Miembro de la Junta en Omnivation AB .
Cargos activos de Leif Niclas Fredrik Löwgren
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Omnivation AB | Director/Miembro de la Junta | - | - |
Historial de carrera de Leif Niclas Fredrik Löwgren
Antiguos cargos conocidos de Leif Niclas Fredrik Löwgren.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| COPPERSTONE RESOURCES AB | Director/Miembro de la Junta | - | 14/05/2019 |
| NEXTCELL PHARMA AB | Director/Miembro de la Junta | 01/01/2017 | - |
| QUIAPEG PHARMACEUTICALS HOLDING AB | Director/Miembro de la Junta | 01/01/2017 | - |
QuiaPEG Pharmaceuticals AB
 QuiaPEG Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology QuiaPEG Pharmaceuticals AB operates as biotech company developing biopharmaceuticals based on a proprietary PEGylation technology platform. The firm’s technology is applicable on proteins, peptides, and small molecules. It develops novel long-acting biopharmaceuticals for the treatment of metabolic disorders. The company was founded by Hans Marcus Bosson in 2012 and is headquartered in Solna, Sweden. | Director/Miembro de la Junta | - | - |
Formación de Leif Niclas Fredrik Löwgren.
| University of Stockholm | Masters Business Admin |
Estadísticas
Internacional
| Suecia | 7 |
Operativa
| Director/Board Member | 5 |
| Masters Business Admin | 1 |
Sectorial
| Health Technology | 4 |
| Non-Energy Minerals | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| COPPERSTONE RESOURCES AB | Non-Energy Minerals |
| NEXTCELL PHARMA AB | Health Technology |
| QUIAPEG PHARMACEUTICALS HOLDING AB | Health Technology |
| Empresas privadas | 2 |
|---|---|
QuiaPEG Pharmaceuticals AB
QuiaPEG Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology QuiaPEG Pharmaceuticals AB operates as biotech company developing biopharmaceuticals based on a proprietary PEGylation technology platform. The firm’s technology is applicable on proteins, peptides, and small molecules. It develops novel long-acting biopharmaceuticals for the treatment of metabolic disorders. The company was founded by Hans Marcus Bosson in 2012 and is headquartered in Solna, Sweden. | Health Technology |
| Omnivation AB |
